Current and emerging therapies for the treatment of pancreatic cancer
Rebecca A Moss, Clifton LeeThe Cancer Institute of New Jersey, New Brunswick, NJ, USAAbstract: Pancreatic adenocarcinoma carries a dismal prognosis and remains a significant cause of cancer morbidity and mortality. Most patients survive less than 1 year; chemotherapeutic options prolong life minimal...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-07-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/current-and-emerging-therapies-for-the-treatment-of-pancreatic-cancer-a4846 |